BMRN vs CDRE · P/E 40, rev $1.76B vs P/E 36, rev $362.6M
Biomarin Pharmaceutical Inc (BMRN) versus Cadre Holdings Inc (CDRE) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Cadre Holdings Inc (CDRE) is a aerospace & defense company listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported CDRE revenue for 2026-06-30 was $362.6M. Net income was $13.4M. CDRE currently screens at market cap $1.28B and trailing P/E 35.7.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. CDRE currently screens at market cap $1.28B and trailing P/E 35.7.
Not investment advice. Open the BMRN and CDRE stock pages for the full models.
Not investment advice.